ApprovalTrail

Approval · Notice of Compliance 4071 · 1997

ALLERDROP: Notice of Compliance 4071

Issued February 12, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4071
Date
February 12, 1997
Company
Pharmascience Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
Product name change
Therapeutic class
Antiallergic agent

Products in this notice

BrandDINStatus today
ALLERDROP02230692—

Medicinal ingredients